LifeVantage Co. (NASDAQ:LFVN) Announces $0.04 Quarterly Dividend

LifeVantage Co. (NASDAQ:LFVN) announced a quarterly dividend on Tuesday, October 29th, Zacks reports. Investors of record on Monday, December 2nd will be given a dividend of 0.04 per share on Monday, December 16th. This represents a $0.16 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend is Monday, December 2nd.

LifeVantage has a dividend payout ratio of 22.2% indicating that its dividend is sufficiently covered by earnings.

LifeVantage Trading Up 0.5 %

LifeVantage stock opened at $13.00 on Thursday. The firm’s 50 day simple moving average is $10.86 and its 200 day simple moving average is $8.35. The firm has a market capitalization of $165.11 million, a PE ratio of 46.18 and a beta of 0.84. LifeVantage has a 1-year low of $4.20 and a 1-year high of $14.71.

LifeVantage (NASDAQ:LFVN) last posted its earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. The business had revenue of $47.21 million for the quarter. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.